About the Symplicity renal denervation system

The Symplicity renal denervation system decreases conduction through the nerves in a way that triggers the body’s own regulation mechanisms to lower blood pressure.

The Symplicity renal denervation system may provide a new treatment option for patients whose blood pressure cannot be controlled with medication alone.

The Symplicity renal denervation system accomplishes RDN, a minimally invasive procedure that disables renal nerves located in the renal artery walls. The system consists of a generator and a flexible catheter. The catheter is introduced through the femoral artery in the upper thigh and is threaded through the renal artery near each kidney. Once in place, the top of the catheter delivers low power radio frequency (RF) energy according to a proprietary algorithm, or pattern, to affect the surrounding sympathetic nerves. The procedure does not involve a permanent implant.

What Is It?


Benefits and Risks


The Symplicity Catheter

The Symplicity catheter is specifically designed for safe endovascular application in the renal artery.

  1. Symplicity is a trademark of Medtronic, Inc. and is registered in one or more countries of the world.


Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.

Last updated: 3 Apr 2012

Section Navigation

Additional information

Take Charge

    • Medtronic RDN Screenshot